Craig Brelsford
Hello. This is Craig Brelsford with RedChip Companies. Thank you for joining today’s event with BioVie, which trades on the NASDAQ under the ticker BIVI. With us today is Cuong Do. President and CEO of BioVie. We will begin with a brief presentation in a moment and then we will answer your questions. Welcome to everyone joining us today on X, YouTube, LinkedIn and other social media platforms.
To submit your question, we invite you to join us on Zoom. Use the link provided. Once in Zoom, click the Q&A button at the bottom of your window and type your question into the text box.
Before we begin, please allow me to read the safe harbor statement. This call may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements pertaining to future financial and/or operating results along with other statements about the future expectations, beliefs, goals, plans or prospects expressed by management constitute forward-looking statements. Any statements that are not historical fact should also be considered forward-looking statements. Of course, forward-looking statements involve risks and uncertainties.
Cuong, please go right ahead.
Cuong Viet Do
President, CEO & Director
Good morning, everyone. Thank you for joining today. My name is Cuong Do. I’m the President and CEO of the company. Give me 1 minute to get my screen share up and running again.
Our company has 2 assets. Bezisterim is a novel modulator of inflammation, and BIV201, which potentially has the potential to become the first drug to treat ascites, which
